search
Back to results

Evaluating Parent Delivered Interventions for Children With Autism

Primary Purpose

Autistic Disorder, Developmental Disabilities

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Pivotal Response Training (PRT)
PACE Therapy
PACE and PRT Hybrid
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Autistic Disorder

Eligibility Criteria

18 Months - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria for autism participants:

  • Children between the ages of 1.6 and 17.11 years of age
  • Males and females
  • Diagnosis of autism based on DSM-IV-TR criteria, an expert clinical evaluation, and ADOS or ADI-R if needed
  • Receiving or will receive a parent delivered intervention to alleviate symptoms related to their diagnosis of autistic disorder
  • Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject

Inclusion Criteria for developmentally delayed participants:

  • Will have an age range between 1.6 and 17.11 years of age
  • Males or females
  • Diagnosis of a developmental delay or disorder based on DSM-IV-TR, ICD-10, and an expert clinical evaluation
  • Have historical evidence of significant abnormal developmental milestones as determined by neurological history
  • Receiving or will receive a parent delivered intervention
  • Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject

Exclusion Criteria for autism participants:

  • Is medically unstable (e.g., more than one seizure a month)
  • Have a medical diagnosis that causes autism like symptomology (e.g., Fragile X, Down syndrome, Angelman's syndrome, tuberous sclerosis, Rett's disorder)

Exclusion Criteria for developmentally delayed subjects:

  • Is medically unstable (e.g., more than one seizure a month)
  • Has a diagnosis of ASD

Sites / Locations

  • Stanford University School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Developmentally Based Intervention

Behaviorally Based Intervention

Arm Description

Outcomes

Primary Outcome Measures

Change in CGI-S (Clinical Global Impression - Severity)
Change in SRS (Social Responsiveness Scale)
Change in CDI (Communicative Development Survey) Score
Change in social and communication behaviors as assessed by standardized laboratory observations

Secondary Outcome Measures

Change in VABS (Vineland Adaptive Behavior Scale) Score
Change in social and communication behaviors as assessed from home videos
Change in PSI (Parenting Stress Index) Score
Change in FES (Family Empowerment Scale) Score
Change in frequency and duration of investigation therapy
Change in demographics data

Full Information

First Posted
June 17, 2013
Last Updated
July 13, 2023
Sponsor
Stanford University
search

1. Study Identification

Unique Protocol Identification Number
NCT01882153
Brief Title
Evaluating Parent Delivered Interventions for Children With Autism
Official Title
Evaluating Parent Delivered Interventions for Children With Autism
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
February 2010 (Actual)
Primary Completion Date
February 18, 2022 (Actual)
Study Completion Date
February 18, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University

4. Oversight

5. Study Description

Brief Summary
The investigators will assess the efficacy of parent delivered interventions in the treatment of social and communication deficits in children with autism. By collecting information about parent and child functioning before and after intervention, the investigators will be able to determine whether the intervention is effective in improving child social communication and reducing parent stress.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autistic Disorder, Developmental Disabilities

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
104 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Developmentally Based Intervention
Arm Type
Experimental
Arm Title
Behaviorally Based Intervention
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Pivotal Response Training (PRT)
Intervention Description
The behaviorally-based intervention is a treatment model that uses the principles of Applied Behavior Analysis (Koegel, Openden, Fredeen, & Koegel, 2006) to increase children's adaptive behaviors and decrease maladaptive behaviors.
Intervention Type
Behavioral
Intervention Name(s)
PACE Therapy
Intervention Description
The developmentally based intervention is grounded in a development theory, that focuses on child-directed interactions with warm and caring individuals that aid in acquiring missed developmental and functional milestones.
Intervention Type
Behavioral
Intervention Name(s)
PACE and PRT Hybrid
Intervention Description
The hybrid based treatment has an eclectic approach that incorporates both systematic (behaviorally-based) and affect-based learning (developmentally-based)that focuses on increasing children's skill development (http://www.pacificautism.org).
Primary Outcome Measure Information:
Title
Change in CGI-S (Clinical Global Impression - Severity)
Time Frame
Difference from Baseline to Week 12
Title
Change in SRS (Social Responsiveness Scale)
Time Frame
Difference from Baseline to Week 12
Title
Change in CDI (Communicative Development Survey) Score
Time Frame
Difference from Baseline to Week 12
Title
Change in social and communication behaviors as assessed by standardized laboratory observations
Time Frame
Difference from Baseline to Week 12
Secondary Outcome Measure Information:
Title
Change in VABS (Vineland Adaptive Behavior Scale) Score
Time Frame
Difference from Baseline to Week 12
Title
Change in social and communication behaviors as assessed from home videos
Time Frame
Difference from Baseline to Week 12
Title
Change in PSI (Parenting Stress Index) Score
Time Frame
Difference from Baseline to Week 12
Title
Change in FES (Family Empowerment Scale) Score
Time Frame
Difference from Baseline to Week 12
Title
Change in frequency and duration of investigation therapy
Time Frame
Difference from Baseline to Week 12
Title
Change in demographics data
Time Frame
Difference from Baseline to Week 12

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Months
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria for autism participants: Children between the ages of 1.6 and 17.11 years of age Males and females Diagnosis of autism based on DSM-IV-TR criteria, an expert clinical evaluation, and ADOS or ADI-R if needed Receiving or will receive a parent delivered intervention to alleviate symptoms related to their diagnosis of autistic disorder Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject Inclusion Criteria for developmentally delayed participants: Will have an age range between 1.6 and 17.11 years of age Males or females Diagnosis of a developmental delay or disorder based on DSM-IV-TR, ICD-10, and an expert clinical evaluation Have historical evidence of significant abnormal developmental milestones as determined by neurological history Receiving or will receive a parent delivered intervention Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject Exclusion Criteria for autism participants: Is medically unstable (e.g., more than one seizure a month) Have a medical diagnosis that causes autism like symptomology (e.g., Fragile X, Down syndrome, Angelman's syndrome, tuberous sclerosis, Rett's disorder) Exclusion Criteria for developmentally delayed subjects: Is medically unstable (e.g., more than one seizure a month) Has a diagnosis of ASD
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antonio Y Hardan, M.D.
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University School of Medicine
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Evaluating Parent Delivered Interventions for Children With Autism

We'll reach out to this number within 24 hrs